Daniel Scherman
Impact in
- Biotechnology top 0.05%
- Microbial Inactivation Methods
- Molecular Biology top 0.2%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- RNA Interference and Gene Delivery 112
- Advanced biosensing and bioanalysis techniques 71
- CRISPR and Genetic Engineering 28
- Genetics 77
- Virus-based gene therapy research 64
- Co-authors
- Barbara Demeneix (2 shared papers)Jean‐Paul Behr (2 shared papers)Frank Lezoualc’h (1 shared paper)Otmane Boussif (1 shared paper)Michel Bessodes (57 shared papers)Cyrille Richard (57 shared papers)Johanne Séguin (49 shared papers)Thomas Maldiney (23 shared papers)
In The Last Decade
Daniel Scherman
417 papers receiving 23.9k citations
Daniel Scherman's Hit Papers
Peers
Comparison fields: 5 of 175
- Biotechnology 2.0k
- Molecular Biology 12.7k
- Genetics 4.0k
- Biomaterials 1.6k
- Cellular and Molecular Neuroscience 1.9k
Countries citing papers authored by Daniel Scherman
This map shows the geographic impact of Daniel Scherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Scherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Scherman more than expected).
Fields of papers citing papers by Daniel Scherman
This network shows the impact of papers produced by Daniel Scherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Scherman. The network helps show where Daniel Scherman may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Scherman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 421 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Hit paper breakdown → | 1995 | 5232 |
| 2 | The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells Hit paper breakdown → | 2014 | 974 |
| 3 | High-efficiency gene transfer into skeletal muscle mediated by electric pulses Hit paper breakdown → | 1999 | 751 |
| 4 | Nanoprobes with near-infrared persistent luminescence for in vivo imaging Hit paper breakdown → | 2007 | 743 |
| 5 | Protective Role of Interleukin-10 in Atherosclerosis Hit paper breakdown → | 1999 | 651 |
| 6 | 2013 | 365 | |
| 7 | 2011 | 364 | |
| 8 | 2018 | 263 | |
| 9 | 2002 | 238 | |
| 10 | 2011 | 231 | |
| 11 | 1989 | 222 | |
| 12 | 2008 | 208 | |
| 13 | 1997 | 200 | |
| 14 | 1998 | 198 | |
| 15 | 2000 | 181 | |
| 16 | 2000 | 178 | |
| 17 | 1990 | 171 | |
| 18 | 1998 | 169 | |
| 19 | 2016 | 164 | |
| 20 | 2012 | 156 |
About Daniel Scherman
Daniel Scherman is a scholar working on Molecular Biology, Genetics, Biomedical Engineering, Materials Chemistry and Cellular and Molecular Neuroscience, having authored 421 papers that have together received 24.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (112 papers), Advanced biosensing and bioanalysis techniques (71 papers), Virus-based gene therapy research (64 papers), Microbial Inactivation Methods (35 papers), Nanoplatforms for cancer theranostics (33 papers), Luminescence Properties of Advanced Materials (30 papers), Neuroscience and Neuropharmacology Research (29 papers) and CRISPR and Genetic Engineering (28 papers). The work is most often cited by research in Biotechnology (2.0k citations), Molecular Biology (12.7k citations), Genetics (4.0k citations), Biomaterials (1.6k citations) and Cellular and Molecular Neuroscience (1.9k citations). Daniel Scherman has collaborated with scholars based in France, Belgium and Israel. Frequent co-authors include Barbara Demeneix, Jean‐Paul Behr, Frank Lezoualc’h, Otmane Boussif, Michel Bessodes, Cyrille Richard, Johanne Séguin, Thomas Maldiney, Michel F. Bureau and Virginie Escriou. Their work appears in journals such as The Journal of Gene Medicine, Gene Therapy, Journal of Controlled Release, Bioconjugate Chemistry and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.